Arkolith/Insider Trading/FNCH/Form 4

Graf Susan E

DirectorFinch Therapeutics Group, Inc. (FNCH) · full profile →Form 4 · filed Jun 9, 2023
Net Buying
Open-Market Buys
$1K
Open-Market Sells
$0
Net Open-Market Flow
$1K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2023Buy(P)5K$0.27$1K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2023Grant(A)10K—$010K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-015177) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML